
Humana (HUM) Stock Forecast & Price Target
Humana (HUM) Analyst Ratings
Bulls say
Humana has revised its earnings per share (EPS) estimate for 2025 to $17.06, a notable increase from the previous estimate of $16.26, driven by solid second-quarter results and updated guidance. The company anticipates year-over-year earnings growth in 2027 as margin improvement initiatives take effect, despite the expectation that the Stars rating will remain stable and not contribute to bonus payments. Additionally, Humana has demonstrated a strong commitment to sustainability, achieving over a 20% reduction in greenhouse gas emissions since 2017, which reflects positively on its operational efficiency and corporate responsibility.
Bears say
Humana's management anticipates a slight decline in 2026 earnings per share (EPS) compared to 2025 due to challenges from the Stars program, which may partially be mitigated by margin initiatives. In a downside scenario, there is a projection that fiscal year 2027 EPS could fall approximately 10% below estimates as the company plans to increase investments aimed at supporting the recovery of the Stars program. Additionally, despite potential benefit cuts by competitors, management believes a benefit gap will persist, indicating ongoing pressure within the competitive landscape.
This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.
Humana (HUM) Analyst Forecast & Price Prediction
Start investing in Humana (HUM)
Order type
Buy in
Order amount
Est. shares
0 shares